Your browser doesn't support javascript.
loading
Hypnotherapy compared to cognitive-behavioral therapy for smoking cessation in a randomized controlled trial.
Batra, Anil; Eck, Sandra; Riegel, Björn; Friedrich, Sibylle; Fuhr, Kristina; Torchalla, Iris; Tönnies, Sven.
Afiliación
  • Batra A; Department for Psychiatry and Psychotherapy, Section for Addiction Research and Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Eck S; Department for Psychiatry and Psychotherapy, Section for Addiction Research and Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Riegel B; Private Practitioner, Hohenwestedt, Germany.
  • Friedrich S; Private Practitioner, Quickborn, Germany.
  • Fuhr K; Department for Psychiatry and Psychotherapy, Section for Addiction Research and Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Torchalla I; West Coast Resiliency Centre, Vancouver, BC, Canada.
  • Tönnies S; Department of Clinical Psychology and Psychotherapy, University Hamburg, Hamburg, Germany.
Front Psychol ; 15: 1330362, 2024.
Article en En | MEDLINE | ID: mdl-38476396
ABSTRACT
Worldwide, more than eight million people die each year as a result of tobacco use. A large proportion of smokers who want to quit are interested in alternative smoking cessation methods, of which hypnotherapy is the most popular. However, the efficacy of hypnotherapy as a tobacco cessation intervention cannot be considered sufficiently proven due to significant methodological limitations in the studies available to date. The aim of the present study was to compare the efficacy of a hypnotherapeutic group program for smoking cessation with that of an established cognitive-behavioral group program in a randomized controlled trial. A total of 360 smokers who were willing to quit were randomly assigned to either hypnotherapy (HT) or cognitive-behavioral therapy (CBT) at two study sites, without regard to treatment preference. They each underwent a 6 weeks smoking cessation course (one 90 min group session per week) and were followed up at regular intervals over a 12 months period. The primary outcome variable was defined as continuous abstinence from smoking according to the Russell standard, verified by a carbon monoxide measurement at three measurement time points. Secondary outcome variables were 7 days point prevalence abstinence during the 12 months follow up and the number of cigarettes the non-quitters smoked per smoking day (smoking intensity). Generalized estimating equations were used to test treatment condition, hypnotic suggestibility, and treatment expectancy as predictors of abstinence. The two interventions did not differ significantly in the proportion of participants who remained continuously abstinent throughout the follow-up period (CBT 15.6%, HT 15.0%) and also regarding the 7 days abstinence rates during the 12 months follow-up (CBT 21.2%, HT 16.7%). However, when controlling for hypnotic suggestibility, CBT showed significantly higher 7 days abstinence rates. In terms of the continuous abstinence rates, it can be concluded that the efficacy of hypnotherapeutic methods for smoking cessation seem to be comparable to established programs such as CBT. Clinical trial registration ClinicalTrials.gov, identifier NCT01129999.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_mente_y_cuerpo / Hipnosis Idioma: En Revista: Front Psychol Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_mente_y_cuerpo / Hipnosis Idioma: En Revista: Front Psychol Año: 2024 Tipo del documento: Article País de afiliación: Alemania